SCHEMBL1948138

SCHEMBL1948138

CCc1c2nc(c(CC)c3ccc([nH]3)c(CC)c3nc(c(CC)c4ccc1[nH]4)C=C3)C=C2

nearest known ligand 0.44

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 4/20 0.44
▸ TOP1 P11387 2/20 0.36
▸ CYCS P99999 2/20 0.35
▸ DDAH1 O94760 1/20 0.34
▸ ENPP2 Q13822 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27806538 0.98 TERT (0.42) TERTTOP1CYCSDDAH1ENPP2
SCHEMBL15162401 0.98 TERT (0.42) TERTTOP1CYCSDDAH1ENPP2
SCHEMBL18510101 0.96 TERT (0.41) TERTTOP1CYCSDDAH1ENPP2
SCHEMBL1228030 0.94 TERT (0.41) TERTTOP1CYCSDDAH1ENPP2
SCHEMBL31392759 0.83 TERT (0.41) TERTTOP1CYCS
SCHEMBL3475623 0.80 MAPT (0.41) TERT
SCHEMBL18510105 0.80 TERT (0.35) TERT
SCHEMBL30567312 0.79 TERT (0.49) TERTTOP1CYCSENPP2
SCHEMBL8601755 0.77 KCNH2 (0.42) TERT
SCHEMBL433614 0.77 KCNH2 (0.42) TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118542429-A Photodynamic sterilization inspection system and method 中国农业大学 2024-08-27 — — CN claimed
CN-104437406-A Preparation method of lignin porous material UNIV GUANGXI 2015-03-25 — — CN claimed
JP-2216447-A — — None — — JP disclosed
CN-118542429-A Photodynamic sterilization inspection system and method 中国农业大学 2024-08-27 — — CN disclosed
CN-109867770-B Conjugated microporous polymer based on porphyrin functional group and preparation method and application thereof 吉林大学 2021-11-30 — — CN disclosed
CN-104488105-B Light emitting element material and light emitting element 东丽株式会社 2017-03-22 — — CN disclosed
CN-102844921-B Fuel cell DAIHATSU MOTOR CO LTD 2015-06-24 — — CN disclosed
CN-104488105-A Light emitting element material and light emitting element TORAY INDUSTRIES 2015-04-01 — — CN disclosed
US-8945791-B2 Oxygen side electrode for a fuel cell DAIHATSU MOTOR CO. LTD. (JP) 2015-02-03 — — US disclosed
US-20130011765-A1 FUEL CELL STC UNM (US) 2013-01-10 — — US disclosed
CN-102844921-A Fuel cell DAIHATSU MOTOR CO LTD 2012-12-26 — — CN disclosed
US-7649091-B2 complex comprising manganese acetate and {[{(Porphine-5,15-diyl)bis[cyclopropyl-diyl]}](2-)-N21,N22,N23, N24 }; reduce damage to cells; preventing or arresting free radical associated diseases or conditions; free radical scavengers EUKARION, INC. (US) 2010-01-19 — — US disclosed
US-7649091-B2 complex comprising manganese acetate and {[{(Porphine-5,15-diyl)bis[cyclopropyl-diyl]}](2-)-N21,N22,N23, N24 }; reduce damage to cells; preventing or arresting free radical associated diseases or conditions; free radical scavengers EUKARION, INC. (US) 2010-01-19 — — US disclosed
EP-2046293-A2 USE OF A CATIONIC COLLOIDAL PREPARATION FOR THE DIAGNOSIS AND TREATMENT OF OCULAR DISEASES Medigene AG (DE) 2009-04-15 — — EP disclosed
WO-2008033444-A2 ANTI-APOPTOTIC BENZODIAZEPINE RECEPTOR LIGAND INHIBITORS EUKARION, INC. (US) 2008-03-20 — — WO disclosed
WO-2008006535-A2 USE OF A CATIONIC COLLOIDAL PREPARATION FOR THE DIAGNOSIS AND TREATMENT OF OCULAR DISEASES MEDIGENE AG (DE) 2008-01-17 — — WO disclosed
US-20060241095-A1 Orally bioavailable low molecular weight metalloporphyrins as antioxidants EUKARION, INC. 2006-10-26 — — US disclosed
EP-1631572-A2 ORALLY BIOAVAILABLE LOW MOLECULAR WEIGHT METALLOPORPHYRINS AS ANTIOXIDANTS EUKARION, INC. (US) 2006-03-08 — — EP disclosed
WO-2005000854-A2 ORALLY BIOAVAILABLE LOW MOLECULAR WEIGHT METALLOPORPHYRINS AS ANTIOXIDANTS EUKARION, INC. (US) 2005-01-06 — — WO disclosed
JP-H02216447-A ANION, COMPOUND AND PH SELECTIVE ELECTRODE YAMAMOTO SEISAKUSHO:KK 1990-08-29 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241095-A1 Orally bioavailable low molecular weight metalloporphyrins as antioxidants SLC40A1, HMOX1, SOD1 TERT 3924/4885TOP1 2805/4885CYCS 586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback